A 33-year-old local male presented with generalized psoriasis of PGA 3. He is the younger brother of case 2, however, with a less severe condition, lower BMI and no associated comorbidities. He was treated with short, irregular courses of narrow-band UVB due to poor compliance and no history of systemic therapy. The patient was screened before administration of etanercept injection. All tests were within normal limits, including IGRA and CXR. The patient showed good response to therapy; during his annual checkup he also showed a positive conversion of IGRA, while CXR and microbiology were negative for TB. He was referred to a pulmonologist who diagnosed the case similarly as LTBI. Anti-TB therapy was given, with a 1-month cessation of etanercept. The patient was followed up for 8 months, with continued efficacy of resumed etanercept injections and no report of side effects. Follow-up of the patient will continue in order to rule out recurrence of TB (table 1).